Non-Dilutive Financing Strategies for Early-Stage Life Sciences Companies
vrijdag 6 november
For life sciences startups, securing funding while preserving equity is critical to long-term success. This workshop explores the key non-dilutive financing options available to companies from startup through Series A, including grants, tax incentives, strategic partnerships, foundation funding, venture debt, and royalty-based financing. Participants will learn how to identify the most suitable funding sources, align financing with development milestones, and build a capital-efficient fundraising strategy that extends runway and minimizes dilution. Through practical examples and case studies, attendees will gain actionable insights to support growth and value creation.
More information about the masterclass you will find here.
If you would like to join (one of) these session, please send Miranda de Regt an e-mail and I will send you the confirmation and final additional information.
Please note: limited number of places available! Availability on first-come, first-served basis.
Date: 6 November 2026
Time: 13.00 – 18.00 hrs.
Venue: UtrechtInc, Utrecht Science Park
Wanneer
- Vrijdag 6 november 2026 13.00 - 18.00 uur
Contact
Transistorweg 7N
6534 AT Nijmegen Plan je route naar Non-Dilutive Financing Strategies for Early-Stage Life Sciences Companies